🚨🚨 In the FIRST of its kind study, we laid down the basis how to use immune therapy to prevent #cancer. 👉 “Can immune therapy prevent pre-clinical cancer from progression? The impact of immune therapy on secondary cancer incidence.” Please check out our abstract in

📢 In our 3rd IM resident led project presented in #ASCO24, the super 🤩 resident Heya Batah, MD led a massive effort 💪💪 to present to the VERY largest and longest real world data on the use of Atezo in extensive NSCLC. Please consider Heya for your fellowship program, she will

Congratulations Heya Batah, MD Cleveland Clinic IM Resident for presenting ASCO #ASCO24 and her mentor Moaath Mustafa Ali, MD, MPH | د. معاذ مصطفى علي Cleveland Clinic MD Cleveland Clinic !! Great job! Richard M. Wardrop III, MD, PhD, FAAP, FACP, SFHM !!

#Oustanding work! Way to represent Dr. Heya Batah, MD 🔥🔥🔥🔥🔥

I couldn't have done it without you, Dr. Ali! Thank you for all your support ☺️

🎧 If you're interested in hearing our findings on the role of Atezolizumab in treatment of extensive stage small cell lung cancer, take a listen to our episode on Cleveland Clinic Cancer Advances! Moaath Mustafa Ali, MD, MPH | د. معاذ مصطفى علي open.spotify.com/episode/08hlac…